Delcath Systems, Inc. Stock
Delcath Systems, Inc. Stock
Delcath Systems, Inc. is currently one of the favorites of our community with 12 Buy predictions and no Sell predictions.
Pros and Cons of Delcath Systems, Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
S********** s********
?
M***** P*******
Cons
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Delcath Systems, Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Delcath Systems, Inc. | - | - | - | - | - | - | - |
| Lightpath Techs A | -2.750% | 6.000% | 36.774% | - | 18.436% | - | - |
| Electrocore Inc. | 12.980% | 27.027% | 17.500% | 28.188% | 23.037% | 39.507% | -76.937% |
| Cardiff Oncology Inc. | 0.550% | 5.578% | 25.592% | -24.929% | 5.578% | 89.016% | -81.597% |
Comments
Delcath Systems (NASDAQ:DCTH) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
Show more
Ratings data for DCTH provided by MarketBeat
Delcath Systems (NASDAQ:DCTH) had its price target lowered by analysts at Stephens from $25.00 to $18.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for DCTH provided by MarketBeat
Delcath Systems (NASDAQ:DCTH) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $23.00 price target on the stock.
Show more
Ratings data for DCTH provided by MarketBeat